The Latest Breaking News on Pharma

With inflation showing no sign of cooling down, the Fed is expected to continue with its rate hikes, raising the chances of a recession. Healthcare stocks have historically provided a cushion in such hazy times. Hence, fundamentally robust stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be safe additions…

Curtis, who represents the 18th Ward on the Chicago City Council, suffered the gunshot wound around noon in the 8200 block of South Christiana Avenue, according to a Chicago police alert.

Reported plans come in bid to clear up long GP waiting lists

Healthcare giant (MRK) has gained more than 20% in 2022. Moreover, it pays handsome dividends to its shareholders. And its attractive valuations and robust profitability make it a better Buy than its peers. Let's discuss this in detail….

The CDC bowed to the Trump administration’s demands to change the editorial process of its weekly scientific journal after warnings from then health secretary Alex Azar to “get in line,” a House investigation found.

NHS Lanarkshire has now vaccinated more than 3000 eligible residents with both the COVID-19 booster and Flu vaccines

LOS ANGELES — California officials are urging doctors to be on alert for any signs of Ebola symptoms among people who have recently traveled to Uganda, the East African nation currently undergoing a significant outbreak.

The British Compressed Gases Association made the plea to Suella Braverman.

The professors said that there was 'a number of breakthroughs' during the Covid vaccine development.

The maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work

Moderna Inc has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people. The biotech company and vaccine alliance GAVI will cancel their existing supply deal for vaccines based on the original coronavirus strain. Instead, Moderna will supply up…